OHSU OPAT-related published work

• Streifel AC, Luis K, Nakrani M, Yu D, Sikka MK, Varley CD, Douglass A, Mayer H, Young K, Lewis JS 2nd. Put the Vanc Down, Flip It and Reverse It: Comparison of Vancomycin and Daptomycin Health Care Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy. Open Forum Infect Dis. 2024 Jul 25;11(8):ofae438. doi: 10.1093/ofid/ofae438. PMID: 39130079; PMCID: PMC11310585.
• Amber C Streifel, Luke C Strnad, Monica K Sikka, Cara D Varley, Jina Makadia, Ellie Sukerman, Alyse H Douglass, Heather Mayer, Kathleen Young, James S Lewis, Dalba Got Back? Use of Dalbavancin for the Treatment of Vertebral Osteomyelitis, Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae070, https://doi.org/10.1093/ofid/ofae070
• Bhagat H, Sikka MK, Sukerman ES, Makadia J, Lewis JS II, Streifel AC.  Evaluation of Opportunities for Oral Antibiotic Therapy in Bone and Joint Infections. Annals of Pharmacotherapy. 2022; online ahead of print.  doi: 10.1177/10600280221101105
• Streifel AC, Varley CD, Ham YY, Sikka MK, Lewis JS II. The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report. BMC Infectious Diseases. 2022;22(1):290. doi: 10.1186/s12879-022-07270-0
• Streifel AC, Sikka MK. The Urgent Need for Medicare Reimbursement for Home Infusion Antibiotics Amidst a Pandemic. Clinical Infectious Diseases. 2020;71(12):3250-1. doi: 10.1093/cid/ciaa658
• Streifel AC, Sikka MK, Bowen CD, Lewis JS II. Dalbavancin use in an academic medical centre and associated cost savings. International Journal of Antimicrobial Agents. 2019;54(5):652-4. doi: 10.1016/j.ijantimicag.2019.08.007
• Felder KK, Marshall LM, Vaz LE, Barnes PD. Risk Factors for Complications during Outpatient Parenteral Antimicrobial Therapy for Adult Orthopedic and Neurosurgical Infections. Southern Medical Journal. 2016;109(1):53-60. doi: 10.14423/SMJ.0000000000000401 

Selected OPAT Abstracts

• Streifel AC, Strnad L, Sukerman E, Makadia JT, Lewis JS II, Douglass AH, Young K, Mayer H, Sikka MK. Dalbavancin for the treatment of vertebral osteomyelitis. Open Forum Infectious Diseases 2022; 9 (Supp 2). doi: 10.1093/ofid/ofac492.817
• Streifel A, Sukerman E, Sikka MK, Makadia J, Lewis JS II, Strnad L. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus. Open Forum Infectious Diseases. 2020;7(Supp 1): S650-S651. doi: 7. S650-S651. 10.1093/ofid/ofaa439.1452.
• Nakrani M, Yu D, Sikka MK, Lewis II JS, Douglass AH, Mayer H, Young K, Streifel AC. Comparison of vancomycin and daptomycin complications and interventions in outpatient parenteral antimicrobial therapy. Open Forum Infect Dis. 2020 Oct;7(Supp 1): S361-S362. doi: 10.1093/ofid/ofaa439.791
• Streifel A, Sikka M, Lewis JS II. Dalbavancin Use in Complicated Infections and-associated Cost-Savings. Open Forum Infectious Diseases. 2019 Oct;6(Supp 2): S362. doi: 10.1093/ofid/ofz360.892
• Felder KK, Vaz LE, Barnes P, Varley CD. Utilizing a post-discharge telephone call in Outpatient Parenteral Antibiotic Therapy (OPAT): findings from a quality improvement project. Open Forum Infect Dis. 2017;4(Suppl 1): S333. doi: 10.1093/ofid/ofx163.790